Quantification of 3-nitrotyrosine levels using a benchtop ion trap mass spectrometry method

Methods in Enzymology

Volumn 396, Issue , 2005, Pages 245-266

  Nicholls, Stephen J ^a   Shen, Zhongzhou ^a   Fu, Xiaoming ^a   Levison, Bruce S ^a   Hazen, Stanley L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; REACTIVE NITROGEN SPECIES;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INFLAMMATORY DISEASE; ION TRAP MASS SPECTROMETRY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

ANIMALIA;

EID: 27744439064     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)96022-9     Document Type: Review

References (34)

1. Abe K., Pan U.H., Watanabe M., Kato T., and Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis Neurosci. Lett. 199 1995 152 154
2. Althaus J.S., Schmidt K.R., Fountain S.T., Tseng M.T., Carroll R.T., Galatsis P., and Hall E.D. LC-MS/MS detection of peroxynitrite-derived 3-nitrotyrosine in rat microvessels Free Radic. Biol. Med. 29 2000 1085 1095
3. Andreadis A.A., Hazen S.L., Comhair S.A., and Erzurum S.C. Oxidative and nitrosative events in asthma Free Radic. Biol. Med. 35 2003 213 225
4. Beal M.F. Oxidatively modified proteins in aging and disease Free Radic. Biol. Med. 32 2002 797 803
5. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide Proc. Natl. Acad. Sci. USA 87 1990 1620 1624
6. Brennan M.L., Wu W., Fu X., Shen Z., Song W., Frost H., Vadseth C., Narine L., Lenkiewicz E., Borchers M.T., Lusis A.J., Lee J.J., Lee N.A., Abu-Soud H.M., Ischiropoulos H., and Hazen S.L. A tale of two controversies: Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species J. Biol. Chem. 277 2002 17415 17427
7. Crow J.P., and Ischiropoulos H. Detection and quantitation of nitrotyrosine residues in proteins: In vivo marker of peroxynitrite Methods Enzymol. 269 1996 185 194
8. Crowley J.R., Yarasheski K., Leeuwenburgh C., Turk J., and Heinecke J.W. Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine Anal. Biochem. 259 1998 127 135
9. Drew B., and Leeuwenburgh C. Aging and the role of reactive nitrogen species Ann. NY Acad. Sci. 959 2002 66 81
10. Fries D.M., Paxinou E., Themistocleous M., Swanberg E., Griendling K.K., Salvemini D., Slot J.W., Heijnen H.F., Hazen S.L., and Ishciropoulos H. Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: Role of reactive oxygen species J. Biol. Chem. 278 2003 22901 22907
11. Frost M.T., Halliwell B., and Moore K.P. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts Biochem. J. 345 2000 453 458
12. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurting H.I., Ischiropoulos H., Trojanowski J.Q., and Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions Science 290 2000 985 989
13. Graham A., Hogg N., Kalyanaraman B., O'Leary V., Darley-Usmar V., and Moncada S. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor FEBS Lett. 330 1993 181 185
14. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S., and Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury J. Clin. Invest. 94 1994 2407 2413
15. Kamisaki Y., Wada K., Nakamoto K., Kishimoto Y., Kitano M., and Itoh T. Sensitive determination of nitrotyrosine in human plasma by isocratic high-performance liquid chromatography J. Chromatogr. B Biomed. Appl. 685 1996 343 347
16. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi, S., Steinbrecher U.P., and Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima J. Biol. Chem. 272 1997 1433 1436
17. MacPherson J.C., Comhair S.A., Erzurum S.C., Klein D.F., Lipscomb M.F., Kavuru M.S., Samoszuk M.K., and Hazen S.L. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species J. Immunol. 166 2001 5763 5772
18. Moriel P., and Abdalla D.S. Nitrotyrosine bound to beta-VLDL-apoproteins: A biomarker of peroxynitrite formation in experimental atherosclerosis Biochem. Biophys. Res. Commun. 232 1997 332 335
19. Podrez E.A., Schmitt D., Hoff H.F., and Hazen S.L. Myeloperoxidase- generated reactive nitrogen species convert low density lipoprotein into an atherogenic form in vitro J. Clin. Invest. 103 1999 1547 1560
20. Riordan J.F., Sokolovsky M., and Vallee B.L. Tetranitromethane. A reagent for the nitration of tyrosine and tyrosyl residues of proteins J. Am. Chem. Soc. 88 1966 4104 4105
21. Samoszuk M., Brennan M.L., To V., Leonor L., Zheng L., Fu X., and Hazen S.L. Association between nitrotyrosine levels and microvascular density in human breast cancer Breast Cancer Res. Treat. 74 2002 271 278
22. Schwedhelm E., Tsikas D., Gutzki F.M., and Frolich J.C. Gas chromatographic-tandem mass spectrometric quantification of free 3-nitrotyrosine in human plasma at the basal state Anal. Biochem. 276 1999 195 203
23. Shigenaga M.K., Lee H.H., Blount B.C., Christen S., Shigeno E.T., Yip H., and Ames B.N. Inflammation and NO(X)-induced nitration: Assay for 3-nitrotyrosine by HPLC with electrochemical detection Proc. Natl. Acad. Sci. USA 94 1997 3211 3216
24. Shishehbor M.H., Aviles R.J., Brennan M.L., Fu X., Goormastic M., Pearce G.L., Gokce N., Keaney J.F. Jr., Penn M.S., Sprecher D.L., Vita J.A., and Hazen S.L. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy JAMA 289 2003 1675 1680
25. Shishehbor M.H., Brennan M.L., Aviles R.J., Fu X., Penn M.S., Sprecher D.L., and Hazen S.L. Statins promote potent systemic antioxidant effects through specific inflammatory pathways Circulation 108 2003 426 431
26. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., and Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease J. Neurosci. 17 1997 2653 2657
27. Szabo C., Salzman A.L., and Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo FEBS Lett. 363 1995 235 238
28. Tanaka K., Shirai T., Nagata E., Dembo T., and Fukuuchi Y. Immunohistochemical detection of nitrotyrosine in postischemic cerebral cortex in gerbil Neurosci. Lett. 235 1997 85 88
29. Vadseth C., Souza J.M., Thomson L., Seagraves A., Nagaswami C., Scheiner T., Torbet J., Vilaire G., Bennett J.S., Murciano J.C., Muzykantov V., Penn M.S., Hazen S.L., Weisel J.W., and Ischiropoulos H. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species J. Biol. Chem. 279 2004 8820 8826
30. Viera L., Ye Y.Z., Estevez A.G., and Beckman J.S. Immunohistochemical methods to detect nitrotyrosine Methods Enzymol. 201 1999 373 381
31. Wu W., Chen Y., d'Avignon A., and Hazen S.L. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: Potential markers for eosinophil-dependent tissue injury in vivo Biochemistry 38 1999 3538 3548
32. Wu W., Samoszuk M.K., Comhair S.A., Thomassen M.J., Farver C.F., Dweik R.A., Kavuru M.S., Erzurum S.C., and Hazen S.L. Eosinophils generate brominating oxidants in allergen-induced asthma J. Clin. Invest. 105 2000 1455 1463
33. Yi D., Ingelse B.A., Duncan M.W., and Smythe G.A. Quantification of 3-nitrotyrosine in biological tissues and fluids: Generating valid results by eliminating artifactual formation J. Am. Soc. Mass Spectrom. 11 2000 578 586
34. Zheng L., Nukuna B., Brennan M.L., Sun M., Goormastic M., Settle M., Schmitt D., Fu X., Thomson L,Fox, P.L., Ischiropoulos H., Smith J.D., Kinter M., and Hazen S.L. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease J. Clin. Invest. 114 2004 529 541